NASDAQ:MMED

MiniMed Group Q3 2026 Earnings Results & Report

MiniMed Group logo
$16.26 -0.73 (-4.30%)
Closing price 04:00 PM Eastern
Extended Trading
$17.04 +0.77 (+4.77%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MiniMed Group reported Q3 2026 earnings on April 17, 2026. The company reported EPS of -$0.47, while revenue was $790 million.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
After Market Closes
Conference Call
7:00 AM ET

MiniMed Group EPS Results

Actual EPS
-$0.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MiniMed Group Revenue Results

Actual Revenue
$790 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

MiniMed Group Q3 2026 Earnings FAQ

MiniMed Group (NASDAQ:MMED) reported earnings of -$0.47 per share for Q3 2026. The report was announced on Friday, April 17, 2026.

MiniMed Group reported revenue of $790 million for Q3 2026.

MiniMed Group Earnings Headlines

MiniMed: The Split-Off Hangover Is Hiding A Full-Stack Product Cycle
MiniMed Group: An Improving Proposition
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
MiniMed Group Inc (MMED) - What Are Analysts Saying About This Stock?
See More MiniMed Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MiniMed Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiniMed Group and other key companies, straight to your email.

About MiniMed Group

MiniMed Group (NASDAQ:MMED) focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery.

The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.

MiniMed’s operations trace to Medtronic’s diabetes business, which developed and marketed diabetes-management products internationally. MiniMed products and services have been offered in multiple markets, though availability varies by location.

View MiniMed Group Profile